Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Electricity thieves cower when slum power women come around October 4, 2017 A Beginner’s PLC Overview, Part 4 of 4: PLC Ladder Logic December 21, 2018 Bringing Engineered Materials to Additive Manufacturing January 22, 2019